The Johnson & Johnson COVID-19 vaccine may be less effective in battling coronavirus variants than other shots, a new study suggests.
The results, published by bioRxiv but not yet peer reviewed or published in a journal, suggest that the mRNA vaccines made…
New study suggests Johnson & Johnson less effective against variants | TheHill – The Hill
Share this article
More News
Stryker Stock Testing Price Floor – Buy Now?
May 2, 2026
Bitcoin is still in charge
May 2, 2026
Your 2026 Crypto Portfolio Roadmap
May 2, 2026
